MultiMedRx sits at No. 504 in our ranking with a Brief Score of 50. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.
Prefer a straight head-to-head? CoreAge Rx vs MultiMedRx.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.
FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.
A rare combination of a rock-bottom $93 semaglutide, brand-name access, LegitScript certification and all-50-state reach.
A rare accredited provider that pairs brand-name access with fair mid-market compounded pricing across all 50 states.
A LegitScript-certified provider that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.
One of the few accredited providers pairing compounded pricing with brand-name access, nationwide.
The most recognizable name in the ranking — Amazon's One Medical routes brand-name GLP-1 care through real primary-care clinicians, but keeps pricing off the record.
A longevity-leaning brand with one of the lowest tracked semaglutide stickers — but a thin disclosure on the rest.
A nationwide women's provider (Gala GLP-1, from AI Coaching Inc) whose cheap compounded-tirzepatide door only opens on a yearly subscription — with, unusually, a brand-name path on the shelf beside it.
Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.